FIELD: veterinary science; pharmaceutics.
SUBSTANCE: group of inventions relates to veterinary pharmaceutics, specifically to the use of a combination of IgM Streptococcus suis protease antigen and Streptococcus suis bacterin serotype 9, sequence type 16, for the protection of pigs against pathogenic infection Streptococcus suis serotype 9, type sequence 16, a single vaccine composition for the protection of pigs against said pathogenic infection, the use of said antigen and bacterin to produce a vaccine for the specified purpose, a method of protecting pigs from said pathogenic infection, use of said bacterin for protecting pigs from said pathogenic infection. Use of a combination of IgM Streptococcus suis protease antigen and bacterin Streptococcus suis serotype 9, type sequence 16, for protection of pigs against pathogenic infection Streptococcus suis serotype 9, type sequence 16. A single vaccine composition for swine protection against pathogenic infection Streptococcus suis serotype 9, sequence type 16 containing a combination of IgM protease antigen Streptococcus suis, Streptococcus suis bacterin serotype 9, sequence type 16, and a pharmaceutically acceptable carrier. Application of IgM Streptococcus suis protease antigen and Streptococcus suis bacterin serotype 9, sequence type 16, for preparing a vaccine for swine protection against pathogenic infection of Streptococcus suis serotype 9, sequence type 16. Method of swine protection against pathogenic infection of Streptococcus suis serotype 9, sequence type 16, by introduction to pigs of IgM protease antigen Streptococcus suis and bacterin Streptococcus suis serotype 9, sequence type 16. Use of bacterin Streptococcus suis serotype 9, type sequence 16, for protection of pigs against pathogenic infection of Streptococcus suis serotype 9, type sequence 16, where said bacterin is administered simultaneously with IgM Streptococcus suis protease antigen.
EFFECT: said group of inventions provides effective protection of pigs from infection with Streptococcus suis serotype 9, type 16 sequence.
9 cl, 1 tbl, 1 ex
Title | Year | Author | Number |
---|---|---|---|
VACCINE FOR PROTECTION AGAINST STREPTOCOCCUS SUIS | 2018 |
|
RU2769573C2 |
VACCINE FOR PROTECTION AGAINST STREPTOCOCCUS SUIS | 2018 |
|
RU2775916C2 |
COMBINED VACCINE | 2019 |
|
RU2777065C1 |
VACCINE FOR PROTECTION AGAINST STREPTOCOCCUS SUIS | 2019 |
|
RU2802072C2 |
NEW HAEMOPHILUS PARASUIS VACCINE | 2020 |
|
RU2822516C1 |
NEW HAEMOPHILUS PARASUIS VACCINE | 2020 |
|
RU2833948C1 |
POLYVALENT INACTIVATED VACCINE AGAINST SWINE STREPTOCOCCOSIS, METHOD FOR ITS PRODUCTION AND USE | 2021 |
|
RU2761379C1 |
METHOD FOR PREVENTIVE TREATMENT OF PIGS | 2017 |
|
RU2780233C2 |
VACCINE AGAINST LAWSONIA INTRACELLULARIS AND PORCINE CIRCOVIRUS 2 | 2014 |
|
RU2672251C1 |
COMBINED PORCINE VACCINE | 2017 |
|
RU2761453C2 |
Authors
Dates
2025-06-06—Published
2021-03-12—Filed